OS Therapies (NYSE-A: OSTX) ("OS Therapies" or "the Company"), a clinical-stage immunotherapy and Antibody Drug Conjugate (ADC) biopharmaceutical company, today announced that Paul Romness, CEO, and ...

ELIAS Animal Health, a leading companion animal cancer therapeutics company, today announced its adoptive cell therapy, ELIAS Cancer Immunotherapy (ECI®), has received full approval from the U.S.

The Company reiterates its intention to submit a BLA with FDA for OST-HER2 in osteosarcoma in the second quarter of 2025, positioning it to receive approval in the fourth quarter of 2025. OST-HER2 has ...

Congressman and former Houston Mayor Sylvester Turner has died at the age of 70. In 2022, he was diagnosed with Osteosarcoma in his jaw.

Background: Osteosarcoma (OS) is the prevalent primary bone cancer, with a high proclivity for local invasion and metastasis. Previous studies have indicated that telomeres are closely related to ...

Osteosarcoma (OS) is the most common primary malignant bone tumor in both humans and dogs. Canine and human OS share significant similarities in clinical presentation, histopathologic features, and ...

A malignant tumor, osteosarcoma, was diagnosed through CT (computed tomography) scans and pathological examination of biopsy samples. After two attempts at “tumor reduction surgery” with no ...